UnitedHealth Group Incorporated (NYSE:UNH) has earned a consensus recommendation of “Buy” from the twenty-six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and twenty-five have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $183.20.
A number of equities research analysts recently issued reports on the stock. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target on the stock in a research note on Monday, May 15th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $188.00 price target on the stock in a research note on Thursday, March 2nd. Mizuho upped their price target on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research note on Tuesday, April 18th. Leerink Swann upped their price target on shares of UnitedHealth Group from $195.00 to $210.00 and gave the company a “hold” rating in a research note on Tuesday, February 28th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $200.00 price target on shares of UnitedHealth Group in a research note on Thursday, April 6th.
Shares of UnitedHealth Group (UNH) traded down 0.67% during trading on Tuesday, hitting $185.25. 3,438,489 shares of the stock were exchanged. The firm has a 50 day moving average of $176.65 and a 200-day moving average of $167.43. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $186.27. The stock has a market cap of $178.52 billion, a PE ratio of 23.71 and a beta of 0.65.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, topping the consensus estimate of $2.17 by $0.20. UnitedHealth Group had a net margin of 4.13% and a return on equity of 21.42%. The firm had revenue of $48.72 billion for the quarter, compared to the consensus estimate of $48.21 billion. During the same quarter in the previous year, the firm earned $1.81 earnings per share. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group will post $9.80 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be issued a $0.75 dividend. The ex-dividend date is Thursday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.63. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s dividend payout ratio is presently 37.36%.
WARNING: “UnitedHealth Group Incorporated (UNH) Receives $183.20 Average Price Target from Analysts” was first reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://sleekmoney.com/unitedhealth-group-incorporated-unh-receives-183-20-average-price-target-from-analysts/1939134.html.
In related news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now directly owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,378 shares of company stock worth $5,285,052. Company insiders own 0.89% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. National Planning Corp raised its stake in UnitedHealth Group by 18.4% in the fourth quarter. National Planning Corp now owns 2,951 shares of the healthcare conglomerate’s stock worth $474,000 after buying an additional 459 shares during the period. RFG Advisory Group LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth $221,000. Aberdeen Asset Management PLC UK raised its stake in UnitedHealth Group by 21.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 662,179 shares of the healthcare conglomerate’s stock worth $105,975,000 after buying an additional 118,949 shares during the period. Barbara Oil Co. raised its stake in UnitedHealth Group by 28.0% in the fourth quarter. Barbara Oil Co. now owns 6,400 shares of the healthcare conglomerate’s stock worth $1,024,000 after buying an additional 1,400 shares during the period. Finally, Rainier Group Investment Advisory LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth $215,000. 86.73% of the stock is owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/unitedhealth-group-incorporated-unh-receives-183-20-average-price-target-from-analysts/1939134.html
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.